GlassScriptPhysician profile
Alexander L Ton
NPI 1306836549
$8,299.35
in general payments reported to CMS, 2019-2025
39 companies · $153 in 2025
The $153 reported for 2025 was more than what a typical General Practice provider received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,818 · 2020: $2,601 · 2021: $1,344 · 2022: $341 · 2023: $423 · 2024: $619 · 2025: $153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,195.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,086.64 | 2019-2024 | Farxiga, Breztri, Airsupra |
| Glaxosmithkline, LLC. | $821.85 | 2019-2025 | Arexvy, Shingrix, Penmenvy |
| Novo Nordisk INC | $677.94 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Teva Pharmaceuticals USA, INC. | $557.00 | 2019-2021 | |
| Amgen INC. | $547.21 | 2019-2024 | Otezla, Repatha |
| Lilly USA, LLC | $540.19 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $424.89 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $421.81 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $416.44 | 2019-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $325.53 | 2019-2024 | Trintellix |
| Amarin Pharma, INC. | $309.80 | 2019-2021 | |
| Abbvie INC. | $303.04 | 2020-2024 | Vraylar |
| Grifols USA, LLC | $268.81 | 2019-2021 | |
| Allergan, INC. | $204.30 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $182.11 | 2019-2021 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Ton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.